Patent: 7,232,919
✉ Email this page to a colleague
Summary for Patent: 7,232,919
Title: | Platinum compounds |
Abstract: | Platinum compounds, pharmaceutically acceptable salts, and prodrugs thereof. Compositions that include the platinum compounds, either alone or in combination with at least one additional therapeutic agent, with a pharmaceutically acceptable carrier. Methods for using the platinum compounds, either alone or in combination with at least one additional therapeutic agent, in the prophylaxis or treatment of proliferative diseases. |
Inventor(s): | Lal; Manjari (Bellevue, WA) |
Assignee: | Sonus Pharmaceuticals, Inc. (Bothell, WA) |
Application Number: | 11/311,909 |
Patent Claims: | see list of patent claims |
Details for Patent 7,232,919
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Recordati Rare Diseases, Inc. | ELSPAR | asparaginase | For Injection | 101063 | 01/10/1978 | ⤷ Try a Trial | 2022-07-16 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |